Literature DB >> 3544829

Hypertension in the elderly.

J R Sowers.   

Abstract

The incidence of hypertension in the geriatric population is very high and is a significant determinant of cardiovascular risk in this group. The tendency for blood pressure to increase with age in westernized societies such as the United States may depend on environmental factors such as diet, stress, and inactivity. Our population tends to become more obese; to consume relatively greater amounts of sodium and lesser amounts of potassium, calcium, and magnesium; and to decrease exercising with increasing age. Senescent changes in the cardiovascular system leading to decreased vascular compliance and decreased baroreceptor sensitivity contribute not only to rising blood pressure but also to an impairment of postural reflexes and orthostatic hypotension. The hallmark of hypertension in the elderly is increased vascular resistance. Greater vascular reactivity in the elderly hypertensive patients may reflect decreased membrane sodium pump activity and decreased beta-adrenergic receptor activity as well as age-related structural changes. Treatment of diastolic hypertension in the elderly is associated with decreased cardiovascular morbidity and mortality. Although treatment of systolic hypertension may not decrease immediate cardiovascular mortality, it appears to decrease the incidence of stroke. The initial therapeutic approach to the elderly hypertensive patient should generally consist of a reduction in salt and caloric intake and an increase in aerobic exercise, i.e., walking. Drug therapy should be initiated with lower doses of medication with a special concern about orthostatic hypotension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3544829     DOI: 10.1016/0002-9343(87)90265-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Lisinopril in elderly patients with hypertension. Long term effects on renal and metabolic function.

Authors:  M S Laher
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

Review 3.  Choosing the optimum therapy for older hypertensive patients.

Authors:  W H Birkenhäger
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

4.  A 5-year longitudinal study of the relationships between stress, coping, and immune cell beta(2)-adrenergic receptor sensitivity.

Authors:  Brent T Mausbach; Kirstin Aschbacher; Paul J Mills; Susan K Roepke; Roland von Känel; Thomas L Patterson; Joel E Dimsdale; Michael G Ziegler; Sonia Ancoli-Israel; Igor Grant
Journal:  Psychiatry Res       Date:  2008-08-16       Impact factor: 3.222

Review 5.  Metabolic syndrome in the elderly.

Authors:  Matthew Bechtold; John Palmer; Joshua Valtos; Catherine Iasiello; James Sowers
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

Review 6.  Hypertension in the elderly: age- and disease-related complications and therapeutic implications.

Authors:  E G Lakatta; J D Cohen; J L Fleg; E D Frohlich; A H Gradman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

7.  The concept of marketing in the public-private partnership in the medical system in Romania.

Authors:  V L Purcărea; B I Coculescu; E C Coculescu
Journal:  J Med Life       Date:  2014

8.  Cardiovascular autonomic response to amlodipine in primary hypertension.

Authors:  Youssouf Radjab; Souad Aboudrar; Fatima Zahra Milouk; Hanan Rkain; Mustapha El Bakkali; Taoufiq Dakka; Leslie Coghlan; Halima Benjelloun
Journal:  ISRN Cardiol       Date:  2012-06-25

9.  Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+.

Authors:  Sari Rastas; Kimmo Mattila; Auli Verkkoniemi; Leena Niinistö; Kati Juva; Raimo Sulkava; Esko Länsimies
Journal:  BMC Geriatr       Date:  2004-03-29       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.